| # | Drug | Count |
|---|---|---|
| 0 | ADALIMUMAB | 190 |
| 1 | INFLIXIMAB | 143 |
| 2 | USTEKINUMAB | 121 |
| 3 | VEDOLIZUMAB | 107 |
| 4 | ADALIMUMAB-AATY | 102 |
| 5 | ADALIMUMAB-ADAZ | 102 |
| 6 | ADALIMUMAB-FKJP | 101 |
| 7 | AZATHIOPRINE | 94 |
| 8 | METHOTREXATE SODIUM | 87 |
| 9 | METHOTREXATE | 76 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | CLINDAMYCIN PHOSPHATE/BENZOYL PEROXIDE/ADAPALENE | 1 | 0.0167 |
| 1 | INFLIXIMAB-DYYB | 31 | 0.0090 |
| 2 | CLEMASTINE FUMARATE | 10 | 0.0072 |
| 3 | USTEKINUMAB-AUUB | 1 | 0.0057 |
| 4 | AZATHIOPRINE SODIUM | 11 | 0.0043 |
| 5 | USTEKINUMAB-STBA | 1 | 0.0027 |
| 6 | ETRASIMOD | 4 | 0.0024 |
| 7 | ADALIMUMAB-AFZB | 6 | 0.0022 |
| 8 | ADALIMUMAB-FKJP | 101 | 0.0022 |
| 9 | ADALIMUMAB-AATY | 102 | 0.0021 |
| # | Drug class | Count |
|---|---|---|
| 0 | Tumor Necrosis Factor Blocker [EPC] | 210 |
| 1 | Interleukin-23 Antagonist [EPC] | 165 |
| 2 | Interleukin-12 Antagonist [EPC] | 123 |
| 3 | Integrin Receptor Antagonist [EPC] | 107 |
| 4 | Corticosteroid [EPC] | 106 |
| 5 | Purine Antimetabolite [EPC] | 94 |
| 6 | Folate Analog Metabolic Inhibitor [EPC] | 76 |
| 7 | Janus Kinase Inhibitor [EPC] | 53 |
| 8 | Aminosalicylate [EPC] | 32 |
| 9 | Nitroimidazole Antimicrobial [EPC] | 20 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Interleukin-23 Antagonist [EPC] | 165 | 0.0016 |
| 1 | Integrin Receptor Antagonist [EPC] | 107 | 0.0012 |
| 2 | Interleukin-12 Antagonist [EPC] | 123 | 0.0012 |
| 3 | Purine Antimetabolite [EPC] | 94 | 0.0010 |
| 4 | Janus Kinase Inhibitor [EPC] | 53 | 0.0003 |
| 5 | Bile Acid Sequestrant [EPC] | 4 | 0.0003 |
| 6 | Aminosalicylate [EPC] | 32 | 0.0003 |
| 7 | Nitroimidazole Antimicrobial [EPC] | 20 | 0.0003 |
| 8 | Substance P/Neurokinin-1 Receptor Antagonist [EPC] | 2 | 0.0002 |
| 9 | Tumor Necrosis Factor Blocker [EPC] | 210 | 0.0002 |